Study Finds AI Misses Psoriasis in Darker Skin
A study found that AI systems struggled to identify psoriasis in images of people with darker skin, with the best models reaching only 25% accuracy, underscoring risks of missed diagnoses. Separately, dermatology experts said older adults should not be denied effective biologics based on age alone, while an Eli Lilly study reported that combining psoriasis drug Taltz with obesity drug Zepbound improved skin clearance and weight loss compared with Taltz alone.
Health · 6 sources · 1dRead itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About ixekizumab
Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.
Everything about ixekizumab →